U.S. Capnography Equipment Market Size, Share & Industry Analysis, By Product Type (Capnometers [By Type {Handheld & Portable}, & Parameter {Single Parameter & Multi-parameter}] & Accessories), By Technology (Mainstream & Sidestream Capnography), By Application (Cardiac Care [Mainstream & Sidestream Capnography], Respiratory Care, Trauma Care, & Others, By End-user (Hospitals [ICU, NICU, Operating Room, ED], Long Term Care Centers, Ambulatory Surgical Centers, Emergency Medical Services, Specialty Clinics, Homecare Settings, & Others), & Country Forecast, 2025-2032

The U.S. capnography equipment market size was valued at USD 222.9 million in 2024. The market is projected to grow from USD 233.5 million in 2025 to USD 354.4 million by 2032, exhibiting a CAGR of 6.1% during the forecast period.

Capnography is a non-invasive method used to measure the concentration and partial pressure of carbon dioxide in patients’ exhaled air. A capnography equipment measures carbon dioxide and displays it in a waveform. These devices are used in various healthcare settings to assess patients’ circulatory, ventilatory, and metabolic status. The growing burden of chronic conditions such as cancer, cardiac arrest, and neurovascular disorders, along with the increasing number of hospital admissions, has been fueling the demand for capnography devices, thereby fueling the market growth.

• For instance, as per the data published by the World Health Organization (WHO) in 2022, there were around 2.26 million new cases of breast cancer, 2.21 million lung cancer cases, and 1.93 million colorectal cancer cases among the total number of new cancer cases recorded.

Moreover, the market consists of well-established and mid-sized market players such as Medtronic, Koninklijke Philips N.V., and Masimo, among others. These companies are focusing on advanced product launches to enhance their product offerings.

Market Dynamics

Market Drivers

Growing Prevalence of Chronic Conditions has been Fueling Demand for Advanced Monitoring Devices

The increasing prevalence of chronic diseases such as cancer, cardiovascular diseases, respiratory disorders, and others has been fueling demand for advanced patient monitoring systems.

• For instance, as per the research data published by the National Center for Biotechnology Information (NCBI) in 2023, around 71.52 million people out of the total population aged 50 and above in the U.S. suffered from at least one chronic disease in 2020. By 2050, this number is expected to grow by 99.5% and is estimated to reach 142.66%.

Capnometers are used during vital sign monitoring of patients. Therefore, the increasing demand for patient monitoring devices has been fueling the demand for capnography devices, thereby boosting the U.S. capnography equipment market share.

Market Restraints

Increasing Number of Product Recalls Restricts Market Growth

In medical devices, products can be recalled from the market due to design flaws, manufacturing defects, device failure, safety issues, and other factors; if not recalled, these devices can cause harm to the patients.

Many capnography devices have been recalled due to defects resulting from issues in their efficiency.

• For instance, the Advisor Vital Signs Monitor (model 9200) with Capnography options installed, a product of Smiths Medical PM, Inc. (a Thermo Fisher Scientific Inc. brand), was recalled in December 2006. The reason for the product recall was incorrect values displayed by the device.

Such product recalls cause decreased customer trust, leading to a decline in the sales of such products, thereby impacting the U.S. capnography equipment market growth.

Market Opportunities

Integration of Telemedicine with Capnography Equipment is Expected to Expand Its Usage

The growing burden of chronic conditions, the increasing number of patient admissions in hospitals and Ambulatory Surgical Centers (ASCs), and an increasing number of healthcare facilities in the U.S. have been fueling the product’s demand. To fulfil this growing demand, key players have been focusing on developing and approving technologically advanced products.

• In September 2022, Medtronic, a U.S. leader in healthcare technology, received U.S. FDA approval for RespArray patient monitors designed for procedural sedation and medical-surgical units. RespArray is designed with market-leading technologies, Nellcor pulse oximetry and Microstream capnography, Electrocardiogram (ECG), Non-invasive Blood Pressure (NiBP), and temperature monitoring. This approval helped the company increase its brand presence.

Market Challenges

Stringent Regulations Restrict Market Growth

Complex clinical trial procedures and stringent regulatory approvals increase the timeline of the medical device approval, thereby acting as a challenge for market growth. Moreover, the delayed timeline also increases the overall cost of the product development and launch.

High Cost of Capnography Equipment and Accessories Limits Its Adoption

Capnography devices are costly, and accessories are required to be replaced regularly. High cost of capnography devices and consumable costs can limit adoption, particularly in budget-sensitive care settings. 

Download Free sample to learn more about this report.

U.S. CAPNOGRAPHY EQUIPMENT MARKET TRENDS

Increasing Adoption of Capnography Devices in Homecare Settings

Initially, capnography equipment was used in hospitals and emergency departments. However, its adoption has recently increased in homecare settings. Due to the increasing demand for capnography equipment in homecare settings, market players have increased their emphasis on developing and launching capnography devices designed for homecare settings.

• In February 2024, GE Healthcare collaborated with Biofourmis, intending to extend patient monitoring outside the hospital with virtual care-at-home solutions to cater to the growing demand among the patient population.

Therefore, the above-mentioned ongoing trend is expected to expand capnography device usage, fueling market growth.

Other Trends

Growing Adoption of Advanced Technologies in Capnography Products

Market players have been focusing on the development and launch of technologically advanced products with the aim of increasing the efficiency of the capnography process. For instance, the market players have been focusing on the development of capnography devices with the integration of multi-parameter monitors, and innovations in portable devices are enhancing respiratory monitoring.

SEGMENTATION ANALYSIS

By Product Type

Growing Prevalence of Chronic Conditions is Responsible for Accessories Segment’s Dominance

By product type, the market is segmented into capnometers and accessories. By type, the capnometer segment is further bifurcated into handheld and portable. Similarly, based on the parameter, the capnometer segment is bifurcated into single parameter and multi-parameter.

The accessories segment dominated the market in 2024 by accounting for the largest revenue share, and is expected to grow at the fastest CAGR during the forecast period. The segment's growth is attributed to the increasing prevalence of neurological disorders, respiratory conditions, and other conditions requiring regular monitoring.  

The capnometers segment is expected to grow significantly during the forecast period. The segment's growth is attributed to the increasing focus of the market players on new, technologically advanced product development and launch.

To know how our report can help streamline your business, Speak to Analyst

By Technology

Mainstream Capnography Led Market Due to Its Different Advantages

By technology, the market is segmented into mainstream capnography and sidestream capnography.

The mainstream capnography segment dominated the market in 2024 and is expected to grow at the fastest CAGR during the forecast period. The segment’s growth is attributed to the various advantages associated with the use of mainstream capnography, which has been fueling its demand in the country.

• For instance, mainstream capnography provides accurate and faster results by directly assessing the ET-CO2 from the breathing circuit.

The sidestream capnography segment is expected to grow considerably during the forecast period due to the presence of major players selling sidestream capnography in the U.S.

• For instance, Drägerwerk AG & Co. KGaA has been selling its Infinity etCO2 Microstream SmartPod product, a sidestream capnography device, in the U.S.

By Application

Respiratory Care Segment Dominated Owing to Growing Burden of Asthma

Based on application, the market is segmented into cardiac care, respiratory care, trauma care, and others. All these segments are sub-segmented into mainstream capnography and sidestream capnography.

The respiratory care segment dominated the market in 2024, fueled by the increasing burden of asthma, chronic obstructive pulmonary disease (COPD), pulmonary embolism, and others.

• For instance, as per the data published in a survey by the Behavioral Risk Factor Surveillance System (BRFSS), in 2023, around 24.4 million adults and 6.9% of children had asthma that year. Moreover, in the same year, around 15.4 million adults suffered from Chronic Obstructive Pulmonary Disease (COPD) in the U.S.

The cardiac care segment is expected to grow at the fastest CAGR during the forecast period. The growing burden of cardiovascular disorders, such as cardiac arrest, is responsible for the increasing usage of capnography equipment in healthcare facilities for cardiac care applications.

By End-user

Increasing Number of Hospital Admissions is Responsible for Segment’s Dominance

On the basis of end-user, the market is segmented into hospitals, long term care centers, ambulatory surgical centers, emergency medical services, specialty clinics, homecare settings, and others. The hospitals segment is further subdivided into ICU, NICU, operating room, ED, and others.

The hospitals segment dominated the market in 2024, owing to the country's increasing number of hospital admissions.

• For instance, as per the information published by the American Hospital Association (AHA), in the U.S., hospital admissions increased from 33.36 million in 2022 to 34.43 million in 2023.

The ambulatory surgical centers are expected to grow at the fastest CAGR during the forecast period. The segment’s growth is attributed to the increasing number of these centers in the country. For instance, as per the data published by MEDPAC, a non-partisan independent legislative branch providing analysis and advice on the Medicare program to the U.S. Congress in 2021, there were around 6,050 Medicare-certified ambulatory surgical centers in the U.S., experiencing a growth of 10% from 2016.

Competitive Landscape

KEY INDUSTRY PLAYERS

Increasing Focus of Market Players on Partnerships with Other Companies to Strengthen Their Product Portfolio

The U.S. capnography equipment market is semi-consolidated, with Medtronic, Koninklijke Philips N.V., and Drägerwerk AG & Co. KGaA among major players. These companies strongly emphasize partnership and collaboration to expand their product portfolio.

• In June 2022, Medtronic collaborated with GE Healthcare and received U.S. Food and Drug Administration and CE approval on integrating advanced INVOS regional oximetry and Microstream capnography technologies on the CARESCAPE precision monitoring platform to strengthen its product portfolio.

Moreover, other players, Masimo, GE HealthCare, and BD, have been focusing on new product launches and attending conferences to strengthen their brand presence in the U.S.

LIST OF KEY U.S. CAPNOGRAPHY EQUIPMENT COMPANIES PROFILED

• Medtronic (Ireland)
• Masimo (U.S.)
• Koninklijke Philips N.V. (Netherlands)
• GE HealthCare (U.S.)
• BD (U.S.)
• Drägerwerk AG & Co. KGaA (Germany)
• Hamilton Medical (Switzerland)
• Infinium Medical (U.S.)

KEY INDUSTRY DEVELOPMENTS

• September 2024 – BD acquired Edwards Lifesciences' critical care product group and renamed it BD Advanced Patient Monitoring. It expanded BD's portfolio of smart connected care solutions with its growing set of leading monitoring technologies, advanced AI-enabled clinical decision tools, and robust innovation pipeline. This helped strengthen the company’s product portfolio.
• August 2024 – Masimo partnered with March of Dimes, the leading non-profit organization fighting to improve health outcomes for all moms and babies, with an aim to support new babies in the Neonatal Intensive Care Units (NICU).
• October 2023 – GE Healthcare collaborated with the Cleveland Clinic to present a study on the ability of the GE Healthcare Portrait Mobile Monitoring Solution to monitor vital signs such as respiratory rate, oxygen saturation, and pulse rate. This helped the company to increase its brand presence.
• April 2021 – Masimo received U.S. FDA approval for Radius PCG with Bluetooth connectivity for the root patient monitoring and connectivity platform, with an aim to strengthen its product portfolio.
• May 2020 – Masimo collaborated with Koninklijke Philips N.V., with an aim to integrate Masimo Nomoline capnography into select IntelliVue MX-series multi-parameter monitors, to help clinicians assess cerebral oximetry and ventilation status.

REPORT COVERAGE

To gain extensive insights into the market, Download for Customization

Report Scope & Segmentation